Product Code: ETC11257327 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Wegovy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Wegovy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Wegovy Market - Industry Life Cycle |
3.4 Israel Wegovy Market - Porter's Five Forces |
3.5 Israel Wegovy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Wegovy Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Israel Wegovy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Wegovy Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Israel Wegovy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing awareness and adoption of innovative diabetes treatments |
4.2.3 Favorable government policies promoting healthcare access and affordability |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 Competition from existing diabetes treatment options |
4.3.3 Economic uncertainties impacting healthcare spending in Israel |
5 Israel Wegovy Market Trends |
6 Israel Wegovy Market, By Types |
6.1 Israel Wegovy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Wegovy Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Wegovy Market Revenues & Volume, By Weight Management, 2021 - 2031F |
6.1.4 Israel Wegovy Market Revenues & Volume, By Diabetes Control, 2021 - 2031F |
6.1.5 Israel Wegovy Market Revenues & Volume, By Appetite Suppression, 2021 - 2031F |
6.1.6 Israel Wegovy Market Revenues & Volume, By Hormonal Therapy, 2021 - 2031F |
6.1.7 Israel Wegovy Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Israel Wegovy Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Wegovy Market Revenues & Volume, By Injection, 2021 - 2031F |
6.2.3 Israel Wegovy Market Revenues & Volume, By Pre-Filled Syringe, 2021 - 2031F |
6.2.4 Israel Wegovy Market Revenues & Volume, By Auto-Injector, 2021 - 2031F |
6.2.5 Israel Wegovy Market Revenues & Volume, By Custom Dosage, 2021 - 2031F |
6.2.6 Israel Wegovy Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.3 Israel Wegovy Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Wegovy Market Revenues & Volume, By Obesity Treatment, 2021 - 2031F |
6.3.3 Israel Wegovy Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Israel Wegovy Market Revenues & Volume, By Chronic Weight Management, 2021 - 2031F |
6.3.5 Israel Wegovy Market Revenues & Volume, By Metabolic Disorders, 2021 - 2031F |
6.3.6 Israel Wegovy Market Revenues & Volume, By Lifestyle Management, 2021 - 2031F |
6.4 Israel Wegovy Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Israel Wegovy Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Israel Wegovy Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Israel Wegovy Market Revenues & Volume, By Pharmaceutical Retailers, 2021 - 2031F |
6.4.5 Israel Wegovy Market Revenues & Volume, By Telemedicine, 2021 - 2031F |
6.4.6 Israel Wegovy Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
7 Israel Wegovy Market Import-Export Trade Statistics |
7.1 Israel Wegovy Market Export to Major Countries |
7.2 Israel Wegovy Market Imports from Major Countries |
8 Israel Wegovy Market Key Performance Indicators |
8.1 Percentage increase in the number of diagnosed diabetes cases in Israel |
8.2 Adoption rate of new diabetes treatments in the market |
8.3 Government funding allocated to diabetes management programs |
9 Israel Wegovy Market - Opportunity Assessment |
9.1 Israel Wegovy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Wegovy Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Israel Wegovy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Wegovy Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Israel Wegovy Market - Competitive Landscape |
10.1 Israel Wegovy Market Revenue Share, By Companies, 2024 |
10.2 Israel Wegovy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |